human
rodent
angiotensin
convert
enzym
carboxymonopeptidas
singl
catalyt
region
whose
express
limit
mainli
endotheli
cell
arteri
arteriol
venul
variou
organ
includ
heart
lung
kidney
loss
lead
cardiomyopathi
kidney
diseas
also
enhanc
pulmonari
cardiac
renal
injuri
addit
peptidas
action
also
function
receptor
sever
acut
respiratori
syndrom
coronaviru
express
necessari
pulmonari
infect
sever
acut
respiratori
syndrom
sar
spread
rapidli
world
lead
signific
morbid
acut
often
lethal
lung
failur
mortal
approxim
despit
therapi
toronto
sar
outbreak
associ
loss
live
consider
burden
healthcar
system
huge
econom
impact
fatal
sar
associ
viraem
respons
suggest
may
affect
organ
interestingli
patient
infect
suffer
cardiac
diseas
includ
systol
diastol
dysfunct
arrhythmia
sudden
death
hypothes
interact
heart
could
contribut
myocardi
inflamm
damag
show
pulmonari
infect
mice
lead
myocardi
manner
coupl
myocardi
mrna
loss
protein
patient
die
sar
presenc
heart
associ
greater
macrophag
infiltr
myocardi
damag
associ
decreas
myocardi
protein
express
result
demonstr
play
key
role
mediat
infect
heart
combin
myocardi
could
underli
pathophysiolog
mechan
heart
diseas
mutant
mice
previous
describ
male
litterm
mutant
control
use
studi
experi
perform
accord
institut
guidelin
beij
strain
isol
use
infect
mice
via
intranas
rout
day
mice
kill
heart
remov
analys
mice
age
week
maintain
steril
environ
inject
periton
unit
encephalomyocard
emc
viru
normal
salin
previous
describ
mice
kill
day
postinfect
heart
asept
remov
frozen
liquid
nitrogen
anim
experi
perform
accord
institut
guidelin
canadian
council
anim
care
greater
toronto
area
ontario
canada
patient
die
sar
patient
underw
autopsi
dr
j
butani
staff
cardiovascular
pathologist
univers
health
network
offici
pathologist
sar
victim
control
group
consist
autopsi
patient
intub
ventil
die
pneumonia
sepsi
time
period
studi
carri
accord
institut
research
ethic
board
review
trichrom
stain
visual
carri
previous
describ
assess
architectur
alter
inflamm
fibrosi
macrophag
specif
stain
use
antibodi
respect
carri
previous
describ
section
pretreat
use
pepsin
digest
method
follow
treatment
mous
monoclon
antibodi
dako
lab
clone
dilut
mississauga
canada
rabbit
polyclon
antibodi
dako
lab
dilut
section
incub
biotinyl
multilink
secondari
antibodi
id
lab
biotechnolog
inc
london
canada
treat
hors
strepavidin
label
reagent
id
lab
biotechnolog
inc
macrophag
count
degre
inflamm
fibrosi
cardiomyocyt
area
obtain
three
section
heart
five
random
view
section
previous
describ
apoptosi
assess
termin
deoxynucleotidyl
dntp
tunel
use
apoptag
plu
kit
intergen
purchas
new
york
ny
usa
immunohistochemistri
carri
use
antibodi
previous
describ
quantifi
previous
describ
ethic
approv
pcr
analysi
human
heart
sampl
perform
previous
describ
revers
transcriptas
reaction
analysi
agreement
diagnost
criteria
sar
establish
variou
agenc
includ
world
health
organ
centr
diseas
control
cdc
homogen
heart
sampl
purifi
use
shredder
column
prior
rna
isol
use
rneasi
mini
kit
qiagen
inc
mississauga
canada
carri
use
real
art
viru
lightcycl
rt
reagent
assay
artu
gmbh
hamburg
germani
lightcycl
platform
roch
diagnost
laval
canada
region
rna
polymeras
gene
amplifi
use
previous
publish
method
western
blot
analysi
myocardi
protein
carri
use
primari
mous
polyclon
antibodi
gener
laboratori
dilut
secondari
goat
antimous
antibodi
bd
bioscienc
mississauga
canada
previous
describ
analysi
myocardi
mrna
express
carri
use
taqman
pcr
use
forward
primer
revers
primer
probe
previous
describ
data
shown
mean
sem
statist
analys
perform
use
spss
softwar
chicago
il
usa
version
use
anova
follow
student
test
multipl
comparison
test
student
use
comparison
two
group
angiotensin
convert
enzym
function
receptor
mediat
pulmonari
infect
examin
myocardi
respons
pulmonari
infect
within
day
follow
infect
mark
presenc
heart
mice
level
reduc
heart
mice
provid
first
evid
depend
myocardi
infect
express
fig
interestingli
process
lead
partial
mrna
express
mice
fig
associ
complet
loss
myocardi
protein
level
fig
result
show
pulmonari
murin
model
sar
clearli
infect
heart
modul
express
deciph
whether
effect
express
mediat
directli
vs
secondari
myocard
process
studi
encephalomyocard
emc
murin
model
viral
myocard
consist
impact
myocardi
mrna
express
emc
viral
myocard
associ
signific
decreas
mrna
fig
contrast
myocardi
protein
level
show
signific
increas
fig
g
suggest
increas
transcript
effici
mrna
andor
reduc
proteolyt
process
result
demonstr
pulmonari
infect
murin
model
lead
myocardi
manner
associ
decreas
myocardi
mrna
express
specif
reduct
myocardi
protein
level
interestingli
sever
cardiac
dysfunct
also
describ
patient
sar
given
high
express
heart
coupl
observ
detect
plasma
sar
patient
examin
whether
pulmonari
infect
lead
myocardi
infect
patient
die
sar
examin
archiv
postmortem
autopsi
heart
tissu
patient
succumb
sar
crisi
evid
myocardi
infect
twenti
patient
confirm
diagnos
sar
detect
lung
studi
revers
chain
reaction
analysi
show
patient
posit
genom
detect
heart
fig
averag
viral
load
copi
per
gram
heart
tissu
age
year
importantli
durat
ill
significantli
shorten
patient
detect
sarscov
heart
n
day
vs
patient
without
heart
n
day
p
fig
result
indic
patient
sar
pulmonari
infect
clearli
lead
infect
heart
result
aggress
ill
earlier
death
show
increas
myocardi
inflamm
interstiti
fibrosi
patient
detect
heart
fig
presenc
myocardi
inflamm
reduc
express
respons
myocardi
infect
associ
patholog
hypertrophi
shown
increas
cardiomyocyt
area
fig
assess
apoptosi
use
tunel
stain
reveal
increas
apoptosi
autopsi
heart
sampl
fig
h
presenc
heart
suggest
could
lead
myocardi
inflamm
use
posit
control
group
consist
patient
die
sar
without
evid
heart
age
year
neg
control
group
consist
patient
die
bacteri
pneumonia
sar
n
age
year
immunohistochem
stain
postmortem
myocardi
tissu
use
marker
reveal
signific
amount
macrophag
infiltr
fig
clearli
increas
patient
heart
minor
elev
patient
without
heart
fig
contrast
immunohistochem
stain
specif
marker
show
myocardi
lymphocyt
infiltr
minim
fig
signific
differ
lymphocyt
count
group
fig
abil
util
receptor
vivo
presenc
heart
suggest
interact
myocardi
system
hypothes
presenc
heart
could
associ
decreas
protein
express
consist
observ
murin
model
immunohistochemistri
myocardi
protein
express
show
presenc
heart
associ
mark
protein
express
fig
quantifi
shown
fig
specif
antibodi
shown
human
recombin
mg
kindli
provid
apeiron
biolog
austria
block
immunostain
nativ
protein
fig
patient
infect
sar
viru
suffer
cardiac
diseas
rang
systol
diastol
dysfunct
arrhythmia
sudden
death
studi
provid
evid
function
myocardi
receptor
vivo
respiratori
infect
murin
model
lead
infect
heart
decreas
myocardi
mrna
express
transcript
mrna
could
lead
decreas
mrna
level
viral
myocard
receptor
describ
multipl
virus
includ
hiv
measl
pulmonari
complet
loss
protein
heart
infect
could
secondari
activ
sar
spike
protein
known
cleav
releas
andor
due
bind
endotheli
cell
lead
endocytosi
ligandreceptor
complex
subsequ
intracellular
degrad
patient
succumb
sar
detect
heart
subject
suggest
capabl
infect
myocardium
suscept
individu
show
patient
heart
die
consider
earlier
suggest
myocardi
infect
associ
aggress
cours
ill
interact
led
cardiomyopathi
like
contribut
significantli
morbid
mortal
patient
sar
consist
cardiac
diseas
patient
succumb
sar
previous
report
bilater
pulmonari
oedema
associ
bilater
pleural
effus
frequent
observ
time
autopsi
increas
myocardi
interstiti
fibrosi
patient
heart
consist
recent
find
show
nucleocapsid
n
protein
potenti
transform
growth
fibrosi
consist
observ
lung
tissu
patient
affect
sar
cd
posit
macrophag
detect
heart
absenc
lymphocyt
invas
contrast
classic
viral
myocard
seen
enterovirus
herpesviru
type
associ
promin
lymphocyt
infiltr
myocardi
inflamm
mediat
predominantli
macrophag
result
product
chemokin
deleteri
effect
myocardi
infect
could
perpetu
prompt
sever
result
increas
ang
ii
action
andor
loss
cardioprotect
effect
ang
andor
activ
sar
spike
protein
lead
increas
releas
myocardi
dysfunct
could
also
secondari
strong
immunopatholog
event
associ
immun
respons
patient
sar
cardiovascular
involv
could
explain
mark
age
depend
mortal
seen
patient
sar
decreas
cardiovascular
reserv
age
consist
key
receptor
patient
diabet
mellitu
express
increas
show
greater
suscept
sar
result
impli
interact
infecti
agent
key
receptorsignal
pathway
cardiovascular
system
may
confer
uniqu
sensit
potenti
viral
infect
inde
interact
subsequ
activ
signal
influenza
viru
import
determin
viral
replic
may
lead
advers
cardiovascular
effect
set
avian
influenza
epidem
divis
cardiolog
depart
medicin
g
oudit
mazankowski
alberta
heart
institut
g
oudit
z
kassiri
depart
physiolog
univers
alberta
edmonton
canada
z
kassiri
nation
key
laboratori
medic
molecular
biolog
peke
union
medic
colleg
beij
china
c
jiang
divis
cardiolog
univers
health
network
univers
toronto
toronto
canada
p
p
liu
divis
infecti
diseas
mount
sinai
hospit
toronto
canada
poutanen
imba
institut
molecular
biotechnolog
austrian
academi
scienc
vienna
austria
j
penning
divis
cardiovascular
patholog
depart
patholog
univers
health
network
toronto
canada
j
butani
